NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has received recognition from two prestigious business publications for its innovation and work environment. Medidata is the only technology company within the global life sciences sector to receive either award.
Forbes magazine named Medidata as one of The World's Most Innovative Growth Companies for 2017, and is ranked 59th globally. Additionally, the company has for the second consecutive year been listed a Best Workplace in New York by FORTUNE, ranking 16th among large companies in New York.
“Our ability to attract and retain an incredibly skilled, diverse, motivated and empowered workforce goes hand-in-hand with the impressive innovation we’re bringing to market,” said Glen de Vries, Medidata president and co-founder. “Investment in the growth and engagement of our employees is a core value for Medidata, and we firmly believe that the return on investment is enormous. Thanks to our strong team, we are able to deliver to our customers innovative technology and solutions, which address real research and business issues they face today, as well as those of the future.”
An example of such technology is Medidata’s Synthetic Control Arm (SCA), which reuses subject level data from multiple historic clinical trials to create a well-matched, patient-level comparator group without recruiting new control patients. SCA provides better science and efficiency for clinical trials by creating a data-based, low-bias, high-confidence comparator for interpreting the uncontrolled treatment.
The Forbes’s list of Most Innovative Growth Companies for 2017 is based on investors’ ability to identify firms they expect to be innovative now and in the future. To qualify, firms need seven years of public financial data between $2-10 billion in market cap and they need to belong to an industry that is known to invest in innovation.
The Best Workplaces in New York is one of a series of rankings by Great Place to Work and FORTUNE based on employee feedback from Great Place to Work–Certified™ organizations. The list considered 137,000 employee surveys about culture, leadership, benefits and other factors crucial to an outstanding employee experience.
Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including more than 850 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world's top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers—from study design and planning through execution, management and reporting.